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Abstract
The SLC1 family of sodium dependent transporters includes the plasma membrane located glutamate
transporters and the neutral amino acid transporters ASCT1 and ASCT2 [1, 49, 36, 37, 7].
Contents
This is a citation summary for SLC1 family of amino acid transporters in the Guide to Pharmacology database
(GtoPdb). It exists purely as an adjunct to the database to facilitate the recognition of citations to and from the
database by citation analyzers. Readers will almost certainly want to visit the relevant sections of the database
which are given here under database links.
GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a
reference work which is most usefully represented as an on-line database. As in any publication this work
should be appropriately cited, and the papers it cites should also be recognized. This document provides a
citation for the relevant parts of the database, and also provides a reference list for the research cited by those
parts.
Please note that the database version for the citations given in GtoPdb are to the most recent preceding version
in which the family or its subfamilies and targets were substantially changed. The links below are to the current
version. If you need to consult the cited version, rather than the most recent version, please contact the GtoPdb
curators.
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    Glutamate transporter subfamily
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                EAAT2(Excitatory amino acid transporter 2)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=869
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                EAAT4(Excitatory amino acid transporter 4)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=871
                EAAT5(Excitatory amino acid transporter 5)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=872
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